Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy ; volume:10 ; number:1 ; day:8 ; month:6 ; year:2020 ; pages:1-12 ; date:12.2020
Annals of intensive care ; 10, Heft 1 (8.6.2020), 1-12, 12.2020
- Creator
-
Claustre, Johanna
Larcher, Romaric
Jouve, Thomas
Truche, Anne-Sophie
Nseir, Saad
Cadiet, Julien
Zerbib, Yoann
Lautrette, Alexandre
Constantin, Jean-Michel
Charles, Pierre-Emmanuel
Daubin, Cedric
Coudroy, Remi
Dellamonica, Jean
Argaud, Laurent
Phelouzat, Pierre
Contou, Damien
Pocquet, Juliette
Voiriot, Guillaume
Navellou, Jean-Christophe
Lavagne, Pierre
Durand, Michel
Cornet, Muriel
Schwebel, Carole
Terzi, Nicolas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13613-020-00673-9
- URN
-
urn:nbn:de:101:1-2020081920001446284939
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Claustre, Johanna
- Larcher, Romaric
- Jouve, Thomas
- Truche, Anne-Sophie
- Nseir, Saad
- Cadiet, Julien
- Zerbib, Yoann
- Lautrette, Alexandre
- Constantin, Jean-Michel
- Charles, Pierre-Emmanuel
- Daubin, Cedric
- Coudroy, Remi
- Dellamonica, Jean
- Argaud, Laurent
- Phelouzat, Pierre
- Contou, Damien
- Pocquet, Juliette
- Voiriot, Guillaume
- Navellou, Jean-Christophe
- Lavagne, Pierre
- Durand, Michel
- Cornet, Muriel
- Schwebel, Carole
- Terzi, Nicolas
- SpringerLink (Online service)
Other Objects (12)
Immunogenic Cell Death in Hematological Malignancy Therapy
The role of BCL11B in hematological malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands
Correction: Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial
Mucormycosis originated total maxillary and cranial base osteonecrosis: a possible misdiagnosis to malignancy
Management strategy for hematological malignancy patients with acute respiratory failure
Gastrointestinal Mucormycosis
Colonic mucormycosis
Immunogenic Cell Death in Hematological Malignancy Therapy
The role of BCL11B in hematological malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands
Correction: Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial
Mucormycosis originated total maxillary and cranial base osteonecrosis: a possible misdiagnosis to malignancy
Management strategy for hematological malignancy patients with acute respiratory failure
Gastrointestinal Mucormycosis
Colonic mucormycosis
Immunogenic Cell Death in Hematological Malignancy Therapy
The role of BCL11B in hematological malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands
Correction: Management of hematological patients requiring emergency chemotherapy in the intensive care unit
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial
Mucormycosis originated total maxillary and cranial base osteonecrosis: a possible misdiagnosis to malignancy
Management strategy for hematological malignancy patients with acute respiratory failure
Gastrointestinal Mucormycosis